{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:21:55Z","timestamp":1790641315235,"version":"4.1.0"},"reference-count":86,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T00:00:00Z","timestamp":1647993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Can J Anesth\/J Can Anesth"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s12630-022-02230-3","type":"journal-article","created":{"date-parts":[[2022,3,23]],"date-time":"2022-03-23T22:03:34Z","timestamp":1648073014000},"page":"756-773","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Mapping the current evidence on the anesthetic management of adult patients with neuromuscular disorders\u2014a scoping review","Cartographie des donn\u00e9es probantes actuelles sur la prise en charge anesth\u00e9sique des patients adultes atteints de maladies neuromusculaires\u00a0: une \u00e9tude de port\u00e9e"],"prefix":"10.1007","volume":"69","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7735-3267","authenticated-orcid":false,"given":"Luuk R.","family":"van den Bersselaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelief","family":"Gubbels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheila","family":"Riazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Heytens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Jungbluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol C.","family":"Voermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc M. J.","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,23]]},"reference":[{"key":"2230_CR1","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.ncl.2016.06.017","volume":"34","author":"JM Bhatt","year":"2016","unstructured":"Bhatt JM. The epidemiology of neuromuscular diseases. Neurol Clin 2016; 34: 999-1021.","journal-title":"Neurol Clin"},{"key":"2230_CR2","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1016\/j.nmd.2019.10.010","volume":"29","author":"L Benarroch","year":"2019","unstructured":"Benarroch L, Bonne G, Rivier F, Hamroun D. The 2020 version of the gene table of neuromuscular disorders (nuclear genome). Neuromuscul Disord 2019; 29: 980-1018.","journal-title":"Neuromuscul Disord"},{"key":"2230_CR3","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.ahj.2003.08.008","volume":"147","author":"D Bhakta","year":"2004","unstructured":"Bhakta D, Lowe MR, Groh WJ. Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I. Am Heart J 2004; 147: 224-7.","journal-title":"Am Heart J"},{"key":"2230_CR4","doi-asserted-by":"publisher","first-page":"91","DOI":"10.3233\/JND-150132","volume":"3","author":"AD Posner","year":"2016","unstructured":"Posner AD, Soslow JH, Burnette WB, et al. The correlation of skeletal and cardiac muscle dysfunction in duchenne muscular dystrophy. J Neuromuscul Dis 2016; 3: 91-9.","journal-title":"J Neuromuscul Dis"},{"key":"2230_CR5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1055\/s-2002-33028","volume":"23","author":"VA DePalo","year":"2002","unstructured":"DePalo VA, McCool FD. Respiratory muscle evaluation of the patient with neuromuscular disease. Semin Respir Crit Care Med 2002; 23: 201-9.","journal-title":"Semin Respir Crit Care Med"},{"key":"2230_CR6","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/mus.26014","volume":"57","author":"NJ Silvestri","year":"2018","unstructured":"Silvestri NJ, Ismail H, Zimetbaum P, Raynor EM. Cardiac involvement in the muscular dystrophies. Muscle Nerve 2018; 57: 707-15.","journal-title":"Muscle Nerve"},{"key":"2230_CR7","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/ALN.0000000000001877","volume":"128","author":"RS Litman","year":"2018","unstructured":"Litman RS, Griggs SM, Dowling JJ, Riazi S. Malignant hyperthermia susceptibility and related diseases. Anesthesiology 2018; 128: 159-67.","journal-title":"Anesthesiology"},{"key":"2230_CR8","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1097\/00000542-200601000-00022","volume":"104","author":"JA Martyn","year":"2006","unstructured":"Martyn JA, Richtsfeld M. Succinylcholine-induced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms. Anesthesiology 2006; 104: 158-69.","journal-title":"Anesthesiology"},{"key":"2230_CR9","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1046\/j.1460-9568.1999.00703.x","volume":"11","author":"U Fischer","year":"1999","unstructured":"Fischer U, Reinhardt S, Albuquerque EX, Maelicke A. Expression of functional alpha7 nicotinic acetylcholine receptor during mammalian muscle development and denervation. Eur J Neurosci 1999; 11: 2856-64.","journal-title":"Eur J Neurosci"},{"key":"2230_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.nmd.2004.10.017","volume":"15","author":"W Klingler","year":"2005","unstructured":"Klingler W, Lehmann-Horn F, Jurkat-Rott K. Complications of anaesthesia in neuromuscular disorders. Neuromuscul Disord 2005; 15: 195-206.","journal-title":"Neuromuscul Disord"},{"key":"2230_CR11","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1097\/EJA.0000000000000672","volume":"34","author":"M Schieren","year":"2017","unstructured":"Schieren M, Defosse J, B\u00f6hmer A, Wappler F, Gerbershagen MU. Anaesthetic management of patients with myopathies. Eur J Anaesthesiol 2017; 34: 641-9.","journal-title":"Eur J Anaesthesiol"},{"key":"2230_CR12","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1097\/ACO.0000000000000466","volume":"30","author":"JA Katz","year":"2017","unstructured":"Katz JA, Murphy GS. Anesthetic consideration for neuromuscular diseases. Curr Opin Anaesthesiol 2017; 30: 435-40.","journal-title":"Curr Opin Anaesthesiol"},{"key":"2230_CR13","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2020-002633","author":"LR van den Bersselaar","year":"2020","unstructured":"van den Bersselaar LR, Snoeck MM, Gubbels M, et al. Anaesthesia and neuromuscular disorders: what a neurologist needs to know. Pract Neurol 2020. https:\/\/doi.org\/10.1136\/practneurol-2020-002633.","journal-title":"Pract Neurol"},{"key":"2230_CR14","doi-asserted-by":"publisher","unstructured":"van den Bersselaar LR, Riazi S, Snoeck M, Jungbluth H, Voermans NC; Anaesthesia and Neuromuscular Disorders Working Group. 259th ENMC international workshop: anaesthesia and neuromuscular disorders 11 December, 2020 and 28-29 May, 2021. Neuromuscul Disord 2021. https:\/\/doi.org\/10.1016\/j.nmd.2021.11.005.","DOI":"10.1016\/j.nmd.2021.11.005"},{"key":"2230_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/1748-5908-5-69","author":"D Levac","year":"2010","unstructured":"Levac D, Colquhoun H, O\u2019Brien KK. Scoping studies: advancing the methodology. Implement Sci 2010. https:\/\/doi.org\/10.1186\/1748-5908-5-69.","journal-title":"Implement Sci"},{"key":"2230_CR16","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med 2018; 169: 467-73.","journal-title":"Ann Intern Med"},{"key":"2230_CR17","first-page":"287","volume":"13","author":"C Lockwood","year":"2019","unstructured":"Lockwood C, Dos Santos KB, Pap R. Practical guidance for knowledge synthesis: scoping review methods. Asian Nurs Res (Korean Soc Nurs Sci) 2019; 13: 287-94.","journal-title":"Asian Nurs Res (Korean Soc Nurs Sci)"},{"key":"2230_CR18","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/00000542-200008000-00011","volume":"93","author":"R Mann","year":"2000","unstructured":"Mann R, Blobner M, Jelen-Esselborn S, Busley R, Werner C. Preanesthetic train-of-four fade predicts the atracurium requirement of myasthenia gravis patients. Anesthesiology 2000; 93: 346-50.","journal-title":"Anesthesiology"},{"key":"2230_CR19","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1097\/EJA.0000000000000257","volume":"32","author":"M Fujimoto","year":"2015","unstructured":"Fujimoto M, Terasaki S, Nishi M, Yamamoto T. Response to rocuronium and its determinants in patients with myasthenia gravis: a case-control study. Eur J Anaesthesiol 2015; 32: 672-80.","journal-title":"Eur J Anaesthesiol"},{"key":"2230_CR20","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1213\/01.ANE.0000140783.39597.FD","volume":"100","author":"MJ Caron","year":"2005","unstructured":"Caron MJ, Girard F, Girard DC, et al. Cisatracurium pharmacodynamics in patients with oculopharyngeal muscular dystrophy. Anesth Analg 2005; 100: 393-7.","journal-title":"Anesth Analg"},{"key":"2230_CR21","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1002\/mus.24904","volume":"53","author":"JT Alshaikh","year":"2016","unstructured":"Alshaikh JT, Amdur R, Sidawy A, Trachiotis G, Kaminski HJ. Thymectomy is safe for myasthenia gravis patients: analysis of the NSQIP database. Muscle Nerve 2016; 53: 370-4.","journal-title":"Muscle Nerve"},{"key":"2230_CR22","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1093\/ejcts\/ezu530","volume":"48","author":"T Ando","year":"2015","unstructured":"Ando T, Omasa M, Kondo T, et al. Predictive factors of myasthenic crisis after extended thymectomy for patients with myasthenia gravis. Eur J Cardiothorac Surg 2015; 48: 705-9.","journal-title":"Eur J Cardiothorac Surg"},{"key":"2230_CR23","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1007\/s00540-015-1999-7","volume":"29","author":"Y Fujita","year":"2015","unstructured":"Fujita Y, Moriyama S, Aoki S, et al. Estimation of the success rate of anesthetic management for thymectomy in patients with myasthenia gravis treated without muscle relaxants: a retrospective observational cohort study. J Anesth 2015; 29: 794-7.","journal-title":"J Anesth"},{"key":"2230_CR24","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1016\/S0003-4975(01)03080-6","volume":"72","author":"J Kas","year":"2001","unstructured":"Kas J, Kiss D, Simon V, Svastics E, Major L, Szobor A. Decade-long experience with surgical therapy of myasthenia gravis: early complications of 324 transsternal thymectomies. Ann Thorac Surg 2001; 72: 1691-7.","journal-title":"Ann Thorac Surg"},{"key":"2230_CR25","first-page":"13990","volume":"8","author":"W Lu","year":"2015","unstructured":"Lu W, Yu T, Longhini F, Jiang X, Qin X, Jin X. Preoperative risk factors for prolonged postoperative ventilation following thymectomy in myasthenia gravis. Int J Clin Exp Med 2015; 8: 13990-6.","journal-title":"Int J Clin Exp Med"},{"key":"2230_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1213\/ANE.0000000000004239","volume":"130","author":"H Mouri","year":"2020","unstructured":"Mouri H, Jo T, Matsui H, Fushimi K, Yasunaga H. Effect of sugammadex on postoperative myasthenic crisis in myasthenia gravis patients: propensity score analysis of a Japanese nationwide database. Anesth Analg 2020; 130: 367-73.","journal-title":"Anesth Analg"},{"key":"2230_CR27","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4328\/ACAM.20485","volume":"12","author":"S Saylan","year":"2021","unstructured":"Saylan S, Akdogan A. Anesthesia and neuromuscular block management in thymectomies performed in cases of thymoma and myasthenia gravis: a retrospective study. J Clin Anal Med 2021; 12: 327-31.","journal-title":"J Clin Anal Med"},{"key":"2230_CR28","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.2147\/TCRM.S93009","volume":"11","author":"T Vymazal","year":"2015","unstructured":"Vymazal T, Krecmerova M, Bicek V, Lischke R. Feasibility of full and rapid neuromuscular blockade recovery with sugammadex in myasthenia gravis patients undergoing surgery - a series of 117 cases. Ther Clin Risk Manag 2015; 11: 1593-6.","journal-title":"Ther Clin Risk Manag"},{"key":"2230_CR29","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1177\/0310057X0102900106","volume":"29","author":"AR Imison","year":"2001","unstructured":"Imison AR. Anaesthesia and myotonia--an Australian experience. Anaesth Intensive Care 2001; 29: 34-7.","journal-title":"Anaesth Intensive Care"},{"key":"2230_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76217-9","author":"CS Kim","year":"2021","unstructured":"Kim CS, Park JM, Park D, Kim DH, Park JS. Opioid use may be associated with postoperative complications in myotonic dystrophy type 1 with high-grade muscular impairment. Sci Rep 2021. https:\/\/doi.org\/10.1038\/s41598-020-76217-9.","journal-title":"Sci Rep"},{"key":"2230_CR31","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/j.1468-1331.2009.02942.x","volume":"17","author":"L Kirzinger","year":"2010","unstructured":"Kirzinger L, Schmidt A, Kornblum C, Schneider-Gold C, Kress W, Schoser B. Side effects of anesthesia in DM2 as compared to DM1: a comparative retrospective study. Eur J Neurol 2010; 17: 842-5.","journal-title":"Eur J Neurol"},{"key":"2230_CR32","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1007\/s12630-009-9244-1","volume":"57","author":"TN Weingarten","year":"2010","unstructured":"Weingarten TN, Hofer RE, Milone M, Sprung J. Anesthesia and myotonic dystrophy type 2: a case series. Can J Anesth 2010; 57: 248-55.","journal-title":"Can J Anesth"},{"key":"2230_CR33","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00540-019-02611-x","volume":"33","author":"AM Hoeper","year":"2019","unstructured":"Hoeper AM, Barbara DW, Watson JC, Sprung J, Weingarten TN. Amyotrophic lateral sclerosis and anesthesia: a case series and review of the literature. J Anesth 2019; 33: 257-65.","journal-title":"J Anesth"},{"key":"2230_CR34","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.amjsurg.2008.11.008","volume":"197","author":"RP Onders","year":"2009","unstructured":"Onders RP, Carlin AM, Elmo M, Sivashankaran S, Katirji B, Schilz R. Amyotrophic lateral sclerosis: the Midwestern surgical experience with the diaphragm pacing stimulation system shows that general anesthesia can be safely performed. Am J Surg 2009; 197: 386-90.","journal-title":"Am J Surg"},{"key":"2230_CR35","first-page":"3725","volume":"10","author":"S Liu","year":"2017","unstructured":"Liu S, Liu Z, Zhang J, et al. Anesthetic strategy for percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis patients. Int J Clin Exp Med 2017; 10: 3725-30.","journal-title":"Int J Clin Exp Med"},{"key":"2230_CR36","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1111\/pan.13295","volume":"28","author":"A Boivin","year":"2018","unstructured":"Boivin A, Antonelli R, Sethna NF. Perioperative management of gastrostomy tube placement in Duchenne muscular dystrophy adolescent and young adult patients: a role for a perioperative surgical home. Paediatr Anaesth 2018; 28: 127-33.","journal-title":"Paediatr Anaesth"},{"key":"2230_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-017-0428-x","author":"C Gurrieri","year":"2017","unstructured":"Gurrieri C, Sprung J, Weingarten TN, Warner ME. Patients with glycogen storage diseases undergoing anesthesia: a case series. BMC Anesthesiol 2017. https:\/\/doi.org\/10.1186\/s12871-017-0428-x.","journal-title":"BMC Anesthesiol"},{"key":"2230_CR38","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.jclinane.2016.02.018","volume":"31","author":"AR Mortenson","year":"2016","unstructured":"Mortenson AR, Sprung J, Cavalcante AN, Watson JC, Weingarten TN. Inclusion body myositis and anesthesia: a case series. J Clin Anesth 2016; 31: 282-7.","journal-title":"J Clin Anesth"},{"key":"2230_CR39","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.jclinane.2014.09.009","volume":"26","author":"TN Weingarten","year":"2014","unstructured":"Weingarten TN, Araka CN, Mogensen ME, et al. Lambert-Eaton myasthenic syndrome during anesthesia: a report of 37 patients. J Clin Anesth 2014; 26: 648-53.","journal-title":"J Clin Anesth"},{"key":"2230_CR40","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s12630-011-9528-0","volume":"58","author":"C Gurrieri","year":"2011","unstructured":"Gurrieri C, Kivela JE, Bojani\u0107 K, et al. Anesthetic considerations in mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes syndrome: a case series. Can J Anesth 2011; 58: 751-63.","journal-title":"Can J Anesth"},{"key":"2230_CR41","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1007\/BF03022658","volume":"54","author":"HG Pellerin","year":"2007","unstructured":"Pellerin HG, Nicole PC, Tr\u00e9panier CA, Lessard MR. Postoperative complications in patients with oculopharyngeal muscular dystrophy: a retrospective study. Can J Anesth 2007; 54: 361-5.","journal-title":"Can J Anesth"},{"key":"2230_CR42","first-page":"154","volume":"116","author":"H Kaur","year":"2019","unstructured":"Kaur H, Katyal N, Yelam A, Kumar K, Srivastava H, Govindarajan R. Malignant hyperthermia. Mo Med 2019; 116: 154-9.","journal-title":"Mo Med"},{"key":"2230_CR43","first-page":"405","volume":"34","author":"C Beecroft","year":"2016","unstructured":"Beecroft C, Hough M. Perioperative management of patients with musculoskeletal disease and for the burns patient. Surgery 2016; 34: 405-10.","journal-title":"Surgery"},{"key":"2230_CR44","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1055\/s-0035-1564302","volume":"35","author":"KA Hudson","year":"2015","unstructured":"Hudson KA, Greene JG. Perioperative consultation for patients with preexisting neurologic disorders. Semin Neurol 2015; 35: 690-8.","journal-title":"Semin Neurol"},{"key":"2230_CR45","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.jopan.2018.03.009","volume":"34","author":"VC Muckler","year":"2019","unstructured":"Muckler VC, O\u2019Brien JM, Matson SE, Rice AN. Perianesthetic implications and considerations for myasthenia gravis. J Perianesth Nurs 2019; 34: 4-15.","journal-title":"J Perianesth Nurs"},{"key":"2230_CR46","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1097\/ACO.0000000000000272","volume":"29","author":"Z Sungur","year":"2016","unstructured":"Sungur Z, Sent\u00fcrk M. Anaesthesia for thymectomy in adult and juvenile myasthenic patients. Curr Opin Anaesthesiol 2016; 29: 14-9.","journal-title":"Curr Opin Anaesthesiol"},{"key":"2230_CR47","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2298\/MPNS1610305S","volume":"69","author":"I Spasojevic","year":"2016","unstructured":"Spasojevic I, Hajdukovic D, Komarcevic M, Petrovic S, Jovanovic J, Ciric A. Specific features of anesthesia in patients with myasthenia gravis. Med Pregl 2016; 69: 305-11.","journal-title":"Med Pregl"},{"key":"2230_CR48","first-page":"485","volume":"88","author":"S Collins","year":"2020","unstructured":"Collins S, Roberts H, Hewer I. Anesthesia and perioperative considerations for patients with myasthenia gravis. AANA J 2020; 88: 485-91.","journal-title":"AANA J"},{"key":"2230_CR49","first-page":"S125","volume":"58","author":"K Hoppe","year":"2017","unstructured":"Hoppe K, Pulnien R, Lehman-Horn F, Jurkat-Rott K, G\u00f6sele M, Klingler W. Mitochondrial disorders. An\u00e4sth Intensivmed 2017; 58: S125-33.","journal-title":"Mitochondrial disorders. An\u00e4sth Intensivmed"},{"key":"2230_CR50","doi-asserted-by":"publisher","DOI":"10.1177\/2326409817707770","author":"VC Hsieh","year":"2017","unstructured":"Hsieh VC, Krane EJ, Morgan PG. Mitochondrial disease and anesthesia. J Inborn Errors Metab Screen 2017. https:\/\/doi.org\/10.1177\/2326409817707770.","journal-title":"J Inborn Errors Metab Screen"},{"key":"2230_CR51","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/CJ9.0000000000000059","volume":"46","author":"PC Echeverry-Mar\u00edn","year":"2018","unstructured":"Echeverry-Mar\u00edn PC, Bustamante-Vega AM. Anesthetic implications of muscular dystrophies. Colombian Journal of Anestesiology 2018; 46: 228-39.","journal-title":"Colombian Journal of Anestesiology"},{"key":"2230_CR52","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1212\/CPJ.0000000000000531","volume":"8","author":"T Ashizawa","year":"2018","unstructured":"Ashizawa T, Gagnon C, Groh WJ, et al. Consensus-based care recommendations for adults with myotonic dystrophy type 1. Neurol Clin Pract 2018; 8: 507-20.","journal-title":"Neurol Clin Pract"},{"key":"2230_CR53","first-page":"S667","volume":"56","author":"K Hoppe","year":"2015","unstructured":"Hoppe K, Jurkatt-Rot K, Lehmann-Horn F, Klingler W. Anaesthesia recommendations for patients suffering from myotonic dystrophies type 1 and 2. An\u00e4sth Intensivmed 2015; 56: S667-74.","journal-title":"An\u00e4sth Intensivmed"},{"key":"2230_CR54","first-page":"S583","volume":"57","author":"AL \u00c1lvarez","year":"2016","unstructured":"\u00c1lvarez AL, Fernandes AR. Anesthesia recommendations for patients suffering from limb-girdle muscular dystrophy. An\u00e4sth Intensivmed 2016; 57: S583-9.","journal-title":"An\u00e4sth Intensivmed"},{"key":"2230_CR55","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1055\/s-0035-1558982","volume":"35","author":"JF Brandsema","year":"2015","unstructured":"Brandsema JF, Darras BT. Dystrophinopathies. Semin Neurol 2015; 35: 369-84.","journal-title":"Semin Neurol"},{"key":"2230_CR56","first-page":"S545","volume":"60","author":"P Stourac","year":"2019","unstructured":"Stourac P, Kosinova M. Anaesthesia recommendations for recessive myotonia congenita (Becker\u2019s disease). An\u00e4sth Intensivmed 2019; 60: S545-53.","journal-title":"An\u00e4sth Intensivmed"},{"key":"2230_CR57","first-page":"S525","volume":"56","author":"N Jimenez","year":"2015","unstructured":"Jimenez N, Liston DE. Anaesthesia recommendations for patients suffering from merosin-deficient congenital muscular dystrophy. An\u00e4sth Intensivmed 2015; 56: S525-31.","journal-title":"An\u00e4sth Intensivmed"},{"key":"2230_CR58","first-page":"S20","volume":"61","author":"J Prottengeier","year":"2020","unstructured":"Prottengeier J, Shammas K, Smith J. Anaesthesia recommendations for collagen VI-related myopathy. An\u00e4sth Intensivmed 2020; 61: S20-6.","journal-title":"An\u00e4sth Intensivmed"},{"key":"2230_CR59","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1080\/17425255.2016.1215426","volume":"12","author":"SJ Schaller","year":"2016","unstructured":"Schaller SJ, Lewald H. Clinical pharmacology and efficacy of sugammadex in the reversal of neuromuscular blockade. Expert Opin Drug Metab Toxicol 2016; 12: 1097-108.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"2230_CR60","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/gim.2014.177","volume":"17","author":"S Parikh","year":"2015","unstructured":"Parikh S, Goldstein A, Koenig MK, et al. Diagnosis and management of mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society. Genet Med 2015; 17: 689-701.","journal-title":"Genet Med"},{"key":"2230_CR61","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/aas.12541","volume":"59","author":"M Broman","year":"2015","unstructured":"Broman M, Islander G, M\u00fcller CR. Malignant hyperthermia, a Scandinavian update. Acta Anaesthesiol Scand 2015; 59: 951-61.","journal-title":"Acta Anaesthesiol Scand"},{"key":"2230_CR62","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/ALN.0000000000001878","volume":"128","author":"S Riazi","year":"2018","unstructured":"Riazi S, Kraeva N, Hopkins PM. Malignant hyperthermia in the post-genomics era: new perspectives on an old concept. Anesthesiology 2018; 128: 168-80.","journal-title":"Anesthesiology"},{"key":"2230_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-015-0310-1","author":"H Rosenberg","year":"2015","unstructured":"Rosenberg H, Pollock N, Schiemann A, Bulger T, Stowell K. Malignant hyperthermia: a review. Orphanet J Rare Dis 2015. https:\/\/doi.org\/10.1186\/s13023-015-0310-1.","journal-title":"Orphanet J Rare Dis"},{"key":"2230_CR64","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/FPC.0000000000000393","volume":"30","author":"K Sangkuhl","year":"2020","unstructured":"Sangkuhl K, Dirksen RT, Alvarellos ML, Altman RB, Klein TE. PharmGKB summary: very important pharmacogene information for CACNA1S. Pharmacogenet Genomics 2020; 30: 34-44.","journal-title":"Pharmacogenet Genomics"},{"key":"2230_CR65","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.bja.2020.05.063","volume":"125","author":"H Carvalho","year":"2020","unstructured":"Carvalho H, Verdonck M, Cools W, Geerts L, Forget P, Poelaert J. Forty years of neuromuscular monitoring and postoperative residual curarisation: a meta-analysis and evaluation of confidence in network meta-analysis. Br J Anaesth 2020; 125: 466-82.","journal-title":"Br J Anaesth"},{"key":"2230_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s12871-019-0829-0","author":"Fernandes H dos Santos","year":"2019","unstructured":"dos Santos Fernandes H, Saraiva Ximenes JL, Nunes DI, Ashmawi HA, Vieira JE. Failure of reversion of neuromuscular block with sugammadex in patient with myasthenia gravis: case report and brief review of literature. BMC Anesthesiol 2019. https:\/\/doi.org\/10.1186\/s12871-019-0829-0.","journal-title":"BMC Anesthesiol"},{"key":"2230_CR67","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1097\/ACC.0b013e3182953053","volume":"1","author":"Y Sugi","year":"2013","unstructured":"Sugi Y, Nitahara K, Shiroshita T, Higa K. Restoration of train-of-four ratio with neostigmine after insufficient recovery with sugammadex in a patient with myasthenia gravis. A A Case Rep 2013; 1: 43-5.","journal-title":"A A Case Rep"},{"key":"2230_CR68","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1097\/ALN.0000000000003256","volume":"132","author":"S Kheterpal","year":"2020","unstructured":"Kheterpal S, Vaughn MT, Dubovoy TZ, et al. Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (STRONGER): a multicenter matched cohort analysis. Anesthesiology 2020; 132: 1371-81.","journal-title":"Anesthesiology"},{"key":"2230_CR69","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1097\/00000542-200012000-00030","volume":"93","author":"KA Kleopa","year":"2000","unstructured":"Kleopa KA, Rosenberg H, Heiman-Patterson T. Malignant hyperthermia-like episode in Becker muscular dystrophy. Anesthesiology 2000; 93: 1535-7.","journal-title":"Anesthesiology"},{"key":"2230_CR70","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1213\/ane.0b013e3181aa5cf6","volume":"109","author":"H Gurnaney","year":"2009","unstructured":"Gurnaney H, Brown A, Litman RS. Malignant hyperthermia and muscular dystrophies. Anesth Analg 2009; 109: 1043-8.","journal-title":"Anesth Analg"},{"key":"2230_CR71","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1213\/ANE.0000000000000736","volume":"121","author":"T Breuer","year":"2015","unstructured":"Breuer T, Maes K, Rossaint R, et al. Sevoflurane exposure prevents diaphragmatic oxidative stress during mechanical ventilation but reduces force and affects protein metabolism even during spontaneous breathing in a rat model. Anesth Analg 2015; 121: 73-80.","journal-title":"Anesth Analg"},{"key":"2230_CR72","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1213\/00000539-199205000-00020","volume":"74","author":"T Ide","year":"1992","unstructured":"Ide T, Kochi T, Isono S, Mizuguchi T. Effect of sevoflurane on diaphragmatic contractility in dogs. Anesth Analg 1992; 74: 739-46.","journal-title":"Anesth Analg"},{"key":"2230_CR73","first-page":"172","volume":"7","author":"L Ye","year":"2015","unstructured":"Ye L, Zuo Y, Zhang P, Yang P. Sevoflurane enhances neuromuscular blockade by increasing the sensitivity of skeletal muscle to neuromuscular blockers. Int J Physiol Pathophysiol Pharmacol 2015; 7: 172-7.","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"2230_CR74","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1111\/j.1460-9592.2006.02181.x","volume":"17","author":"B Woloszczuk-Gebicka","year":"2007","unstructured":"Woloszczuk-Gebicka B, Wyska E, Grabowski T. Sevoflurane increases fade of neuromuscular response to TOF stimulation following rocuronium administration in children. A PK\/PD analysis. Paediatr Anaesth 2007; 17: 637-46.","journal-title":"A PK\/PD analysis. Paediatr Anaesth"},{"key":"2230_CR75","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/00000542-199103000-00014","volume":"74","author":"MJ Baurain","year":"1991","unstructured":"Baurain MJ, d\u2019Hollander AA, Melot C, Dernovoi BS, Barvais L. Effects of residual concentrations of isoflurane on the reversal of vecuronium-induced neuromuscular blockade. Anesthesiology 1991; 74: 474-8.","journal-title":"Anesthesiology"},{"key":"2230_CR76","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-015-1112-5","author":"A Kraj\u010dov\u00e1","year":"2015","unstructured":"Kraj\u010dov\u00e1 A, Waldauf P, And\u011bl M, Du\u0161ka F. Propofol infusion syndrome: a structured review of experimental studies and 153 published case reports. Crit Care 2015. https:\/\/doi.org\/10.1186\/s13054-015-1112-5.","journal-title":"Crit Care"},{"key":"2230_CR77","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.bja.2018.12.025","volume":"122","author":"S Hemphill","year":"2019","unstructured":"Hemphill S, McMenamin L, Bellamy MC, Hopkins PM. Propofol infusion syndrome: a structured literature review and analysis of published case reports. Br J Anaesth 2019; 122: 448-59.","journal-title":"Br J Anaesth"},{"key":"2230_CR78","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1002\/jimd.12196","volume":"43","author":"MC De Vries","year":"2020","unstructured":"De Vries MC, Brown DA, Allen ME, et al. Safety of drug use in patients with a primary mitochondrial disease: an international Delphi-based consensus. J Inherit Metab Dis 2020; 43: 800-18.","journal-title":"J Inherit Metab Dis"},{"key":"2230_CR79","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/00000542-200503000-00007","volume":"102","author":"N Sambuughin","year":"2005","unstructured":"Sambuughin N, Holley H, Muldoon S, et al. Screening of the entire ryanodine receptor type 1 coding region for sequence variants associated with malignant hyperthermia susceptibility in the north american population. Anesthesiology 2005; 102: 515-21.","journal-title":"Anesthesiology"},{"key":"2230_CR80","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1213\/ANE.0b013e3182937d8b","volume":"118","author":"S Riazi","year":"2014","unstructured":"Riazi S, Larach MG, Hu C, Wijeysundera D, Massey C, Kraeva N. Malignant hyperthermia in Canada: characteristics of index anesthetics in 129 malignant hyperthermia susceptible probands. Anesth Analg 2014; 118: 381-7.","journal-title":"Anesth Analg"},{"key":"2230_CR81","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1097\/00000542-200211000-00007","volume":"97","author":"N Monnier","year":"2002","unstructured":"Monnier N, Krivosic-Horber R, Payen JF, et al. Presence of two different genetic traits in malignant hyperthermia families: implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility. Anesthesiology 2002; 97: 1067-74.","journal-title":"Anesthesiology"},{"key":"2230_CR82","doi-asserted-by":"publisher","first-page":"C1094","DOI":"10.1152\/ajpcell.00173.2004","volume":"287","author":"RG Weiss","year":"2004","unstructured":"Weiss RG, O\u2019Connell KM, Flucher BE, Allen PD, Grabner M, Dirksen RT. Functional analysis of the R1086H malignant hyperthermia mutation in the DHPR reveals an unexpected influence of the III-IV loop on skeletal muscle EC coupling. Am J Physiol Cell Physiol 2004; 287: C1094-102.","journal-title":"Am J Physiol Cell Physiol"},{"key":"2230_CR83","doi-asserted-by":"publisher","first-page":"7923","DOI":"10.1073\/pnas.1119207109","volume":"109","author":"JM Eltit","year":"2012","unstructured":"Eltit JM, Bannister RA, Moua O, et al. Malignant hyperthermia susceptibility arising from altered resting coupling between the skeletal muscle L-type Ca2+ channel and the type 1 ryanodine receptor. Proc Natl Acad Sci U S A 2012; 109: 7923-8.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2230_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2952","author":"EJ Horstick","year":"2013","unstructured":"Horstick EJ, Linsley JW, Dowling JJ, et al. Stac3 is a component of the excitation-contraction coupling machinery and mutated in Native American myopathy. Nat Commun 2013. https:\/\/doi.org\/10.1038\/ncomms2952.","journal-title":"Nat Commun"},{"key":"2230_CR85","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.1002\/ajmg.a.32370","volume":"146A","author":"DS Stamm","year":"2008","unstructured":"Stamm DS, Aylsworth AS, Stajich JM, et al. Native American myopathy: congenital myopathy with cleft palate, skeletal anomalies, and susceptibility to malignant hyperthermia. Am J Med Genet A 2008; 146A: 1832-41.","journal-title":"Am J Med Genet A"},{"key":"2230_CR86","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/pan.13130","volume":"27","author":"RM Gray","year":"2017","unstructured":"Gray RM. Anesthesia-induced rhabdomyolysis or malignant hyperthermia: is defining the crisis important? Paediatr Anaesth 2017; 27: 490-3.","journal-title":"Paediatr Anaesth"}],"container-title":["Canadian Journal of Anesthesia\/Journal canadien d'anesth\u00e9sie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-022-02230-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12630-022-02230-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12630-022-02230-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T05:50:29Z","timestamp":1700373029000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12630-022-02230-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,23]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["2230"],"URL":"https:\/\/doi.org\/10.1007\/s12630-022-02230-3","relation":{},"ISSN":["0832-610X","1496-8975"],"issn-type":[{"value":"0832-610X","type":"print"},{"value":"1496-8975","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,23]]},"assertion":[{"value":"2 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 January 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 March 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}